CONFERENCE SERIES: Biomarkers & Diagnostics Series
Recorded at: SIXTH ANNUAL NEXT GENERATION DX SUMMIT
Digital Course: Overcoming Challenges of Working with FFPE Samples
About this Product:
The course provides important insights for overcoming challenges of working with FFPE samples for cancer research such as detecting RNA and profiling miRNA expression. Next generation sequencing (NGS) utilizes FFPE samples for clinical retrospective studies. Successful interpretation of the samples depends on the quality of the starting material.
Total Run Time: 1:19:28
Digital Download: $345.00
Single Copy: $345.00
Site License: $1380.00
Agenda at a Glance:
Topics to be covered:
- Profiling miRNA expression
- RNA detection in cancer tissues stored in FFPE samples
- FFPE DNA quality control and its correlation with NGS data
Sidney W. Fu, M.D., Ph.D., Professor & Associate Director, Genomic Medicine and of Medicine, Microbiology, Immunology and Tropical Medicine, George Washington University School of Medicine and Health Sciences
Dr. Sidney W. Fu is a professor, and associate director of Genomic Medicine in the Department of Medicine at the George Washington University. Dr. Fu’s main research is focused on cancer genomics, particularly in identifying and validating biomarkers for early diagnosis and treatment of breast cancer. Dr. Fu’s research program is currently funded by the NCI, Katzen Cancer Research award, Elaine H. Snyder Cancer Research Award and other private foundations.
Beatrice Knudsen, M.D., Ph.D., Medical Director, Translational Pathology, Cedars Sinai Medical Center
Beatrice Knudsen, M.D., Ph.D. is the Medical Director for Cedars-Sinai Advanced Biobank and Director of Translational Pathology at Cedars-Sinai Medical Center. She obtained her M.S. degree in Chemistry at University of Vienna, Austria and received her Ph.D. in Cell Biology and M.D. degrees at Cornell University, New York. She performed her post-doctoral fellowship in the Laboratory of Molecular Oncology at the Rockefeller University in New York and completed her residency in Anatomic Pathology at New York Hospital. Dr. Knusden is board certified in Anatomic Pathology. She has considerable experience with tissue procurement, tissue banking and molecular diagnostics. Further, she performs research in methods to improve quality of harvested tissues (for example, to stabilize phosphorylation and optimize other bioanalytes). In addition, she directs research programs on prostate cancer metastasis and prostate cancer prevention.
About the Conference:
The Next Generation Dx Summit showcases advances in personalized medicine through a comprehensive program encompassing companion diagnostics, infectious disease, cancer molecular markers, point-of-care, inherited disorders, cell-free DNA, commercialization, NGS-based assays in the clinical setting and single-cell sequencing. This event has become the meeting place for major players in the expanding arena of diagnostics and highlights key components of their successful adoption in the clinic and advancement to the market.
Who may be interested in this product (titles):
Bus Dev Mgr
Dir, Translational Pathology
Dir, Bus Dev
Dir Reimb, Gov Affairs
Postdoctoral Fellow, Pathology
Prof & Assoc, Genomic Medicine
Prof & Dir Research Operations, Pathology
Research Technologist, Medical Genome Facility
Researcher, Medical Sciences
Sr Product, Mgr
Sr Scientist, Molecular Characterization & Clinical Assay Dev
Territory Sales Mgr